Background There is an urgent need for novel therapeutic strategies for reversing COVID-19-
related lung inflammation. Recent evidence has demonstrated that the cholesterol-lowering …

Objective To investigate the association between recent statin exposure and risk of severe
COVID-19 infection and all-cause mortality in patients with COVID-19 in Denmark. Design …

The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute
respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury …

We aim to study the association of hyperlipidemia and statin use with COVID-19 severity. We
analysed a retrospective cohort of 717 patients admitted to a tertiary centre in Singapore for …

Background Statins are widely used to treat people with metabolic and cardiovascular
disorders. The effect of statins on coronavirus disease 2019 (COVID-19) is unclear. To …

Introduction Statins may reduce a cytokine storm, which has been hypothesized as a
possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a …

Objective: Although statins are widely prescribed lipid-lowering drugs, there are concerns
about the safety of their use in the context of coronavirus disease 2019 (COVID-19), since …

Background and aims Statin therapy is administered to patients with high cardiovascular
risk. These patients are also at risk for severe course of coronavirus disease 2019 (COVID …

Abstract Background Coronavirus disease-19 (COVID-19) infection is associated with an
uncontrolled systemic inflammatory response. Statins, given their anti-inflammatory …

The severe respiratory illness due to SARS-CoV-2, the virus responsible for coronavirus
disease 2019 (COVID-19), is triggered by an intense pro-inflammatory host response …